Where CLA is permitted, and what the file must show
CLA is sold as a food supplement ingredient, and the route differs by market. The EU reads the supplement framework and the novel-food status for the intended use; the US uses the dietary-supplement route with a new-dietary-ingredient or GRAS file behind it; the UK applies assimilated novel-food and claims rules. The file has to show the source oil, the isomer ratio, the contaminants and the claim boundary before the label is designed.
CLA is sold as a food supplement ingredient on a route that differs by market, and the file has to show the source, the isomer ratio, the contaminants and the claim boundary.
Four checks, not one
An ingredient file is checked at four levels: the ingredient route, the food category, the contaminants and the label with its claims. They fail independently. A lot can meet every heavy-metal limit and sit on the wrong route; a route can be correct and the label omit the allergen statement or the oil load.
The European Union
Food supplements fall under Directive 2002/46/EC, which harmonises vitamins and minerals but leaves other substances to national rules, so conditions can differ between member states. The novel-food Regulation (EU) 2015/2283 sits on top: a food not consumed significantly in the EU before 15 May 1997 needs an authorisation, and authorised novel foods appear in the Union list in Regulation (EU) 2017/2470 with their conditions of use.
The novel-food catalogue records the status for the intended use and should be read before the label is written. CLA has a history of use in food supplements; a CLA-rich oil added to an ordinary food is a different question, with its own novel-food history and, if authorised, its own Union-list entry. As of this review, check the catalogue for the supplement use and the Union list for any food use; both can change, so read the current text. The labelling rules in Regulation (EU) 1169/2011 and the contaminant limits in Regulation (EU) 2023/915 apply in either case.
The UK applies assimilated Regulation (EU) 2015/2283 through the GB novel-food register and the Food Standards Agency, while Northern Ireland follows the EU list; the same entry discipline applies in a different register. Allergen labelling follows the source: CLA from safflower or sunflower oil is not on the Annex II list, but a wheat-derived starch or a soy-derived antioxidant brings its own declaration.
The United States
In the US, CLA is marketed as a dietary ingredient under DSHEA. The FDA does not approve supplements or labels before marketing, so there is no pre-market licence. The framework is safety and labelling: the ingredient has to be lawful, the facility follows the dietary-supplement GMPs in 21 CFR 111, and the label follows 21 CFR 101. A new dietary ingredient needs a notification at least 75 days before marketing unless its history of use takes it outside the requirement.
CLA-rich oils have GRAS notices for specified food uses, with the substance, the source and the use level defined in each notice. GRAS status for a food use is not the same as a supplement route, and a notice for one oil is not evidence for another. The supplier should name the notification or notice its material relies on, and the buyer should keep that reference. CLA from safflower or sunflower oil is not a major allergen, but a starch carrier or a soy-derived antioxidant can bring its own declaration.
Contaminants and the specification
| Parameter | Catalog limit | EU supplement ceiling | Note |
|---|---|---|---|
| Lead | ≤3 mg/kg | 3.0 mg/kg | Regulation (EU) 2023/915 |
| Cadmium | ≤1 mg/kg | 1.0 mg/kg | Same regulation |
| Mercury | ≤0.1 mg/kg | 0.10 mg/kg | Same regulation |
| Arsenic | ≤2 mg/kg | No harmonised maximum | National or customer limit |
| Peroxide value | ≤5.0 meq/kg | Not a regulatory maximum | Oxidation limit, not a contaminant |
| p-Anisidine value | ≤20.0 | Not a regulatory maximum | Oxidation limit |
| Microbiology | APC ≤1,000 cfu/g; yeast and mould ≤100 cfu/g; E. coli and Salmonella absent | Set by the specification | Confirm the customer's criteria |
Arsenic has no harmonised EU maximum for supplements, so the catalog limit is a customer-facing specification rather than a European legal limit. The limit applies to the finished product, so calculate it on the formula, not only the powder.
The claim boundary
In the EU and the UK, health claims are governed by Regulation 1924/2006 and the GB register that mirrors it. Only authorised claims may be used, and a claim that is not on the register is not made compliant by a footnote. As of this review, the EU Register of nutrition and health claims lists no authorised health claim for CLA. CLA has no NRV, so “high in” or “source of” claims do not apply; fat claims follow the fat content, which the oil load drives.
In the US, a structure/function claim is allowed for a dietary supplement with the required disclaimer. A disease claim is not allowed unless it is an authorised qualified health claim; otherwise it turns the product into a drug. The wording decides. The supplier provides the specification; the brand owns the claim. No disease-related claim belongs on a CLA specification, COA or label.
The file a buyer should hold
| Document | What it proves | Common gap |
|---|---|---|
| Specification | Grade, source, isomer ratio, oil load, carrier, limits and methods | No isomer ratio or oil load |
| Batch COA | The lot was released against the specification | Results copied from the range |
| Source and allergen statement | The oil source, the starch source and the antioxidant | “Allergen-free” with no carrier detail |
| Novel-food status (EU) | The catalogue or Union-list basis for the intended use | A generic “EU approved” line |
| NDI or GRAS reference (US) | The safety route for the exact oil | GRAS cited for a different use |
| SDS and stability data | Handling, storage and the shelf-life basis | A date with no study behind it |
| Contaminant and micro data | The lot meets the agreed limits | A panel without methods or limits of quantification |
| Label artwork | Ingredient name, oil load, carrier, allergen and claims | An isomer named without a specification |
The compliance checklist
- Name the exact grade, oil source and isomer ratio, and match them to the route for the destination.
- Confirm the CLA result and the GC method on the specification.
- Check the catalogue or Union-list entry for the intended use, and the NDI or GRAS reference for the US.
- Check the starch and antioxidant sources, and the allergen statement that follows.
- Compare lead, cadmium, mercury, arsenic and microbiology with the applicable limits.
- Check the label: ingredient name, oil load, carrier, fat declaration, allergen and storage.
- Keep the claim inside the authorised list; no disease-related wording.
- Hold the specification, COA, SDS, stability data and route references in one dated file.
The route references are on the EU regulatory page, the US regulatory page and the UK regulatory page. The allergen list is explained in the Annex II glossary entry, the certificate lines are on the COA page, and the source and isomer decision is set out on the CLA isomer page.
Related documents
Send the specification you intend to use — grade, quantity and destination market — and we will reply with the batch COA, the technical data sheet and a quotation.
Request a quotation